[Federal Register Volume 68, Number 150 (Tuesday, August 5, 2003)]
[Notices]
[Page 46225]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-19813]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 25, 2002, and published in the Federal 
Register on November 7, 2002, (67 FR 67870), Aldrich Chemical Company 
Inc., dba Isotec, 3858 Benner Road, Miamisburg, Ohio 45342-4304, made 
application to the Drug Enforcement Administration for registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
Aminorex (1585)............................  I
Gamma hydroxybutyric acid (2010)...........  I
Methaqualone (2565)........................  I
Lysergic acid dethylamide (7315............  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
2,5-Dimethoxyamophetamine (7396)...........  I
3,4-Methylenedioxyamphetamine (7400).......  I
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxy-methamphetamine (7405)..  I
4-Methoxyamphetamine (7411)................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Acetylmethadol (9601)......................  I
Alphacetylmethadol Except Levo-              I
 Alphacetylmethadol (9603).
Normethadone (9635)........................  I
3-Methylfentanyl (9813)....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobartital (2270).......................  II
Secobarbital (2315)........................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
Phenylacetone (8501).......................  II
1-Piperidinocyclohexane-carbonitrile (8603)  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecogonine (9180)....................  II
Ethylmorphine (9190).......................  II
Hydrocodone (9193).........................  II
Isomethadone (9226)........................  II
Meperidine (9230)..........................  II
Meperidine intermediate-A (9232)...........  II
Merperidine intermediate-B (9233)..........  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk, (non-dosageforms)  II
 (9273).
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to produce standards for analytical laboratories.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Aldrich Chemical Company Inc., dba 
Isotec, to manufacture the listed controlled substances is consistent 
with the public interest at this time. DEA has investigated Aldrich 
Chemical Company Inc., dba Isotec, to ensure that the company's 
registration is consistent with the public interest. This investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
is granted.

    Dated: July 22, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-19813 Filed 8-4-03; 8:45 am]
BILLING CODE 4410-09-M